Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy.

Autoimmunity reviews - 1 Feb 2013

Maiti Amit K, Nath Swapan K

Abstract excerpt

Numerous genes/SNPs in autoimmune diseases (ADs) are identified through genome-wide association studies (GWAS) and likely to contribute in developing autoimmune phenotypes. Constructions of biologically meaningful pathways are necessary to determine how these genes interact with each other and with other small molecules to develop various complex AD phenotypes prior to beginning time-consuming rigorous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Diseases
Share to Autoimmunity
Share to Epistasis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Regulatory Networks

Share to Genome-Wide Association Study

Share to Pharmacogenetics

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 23000205
DOI: 10.1016/j.autrev.2012.09.001
PMCID: PMC3577986

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy.PMID 23000205Read ↗

Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.Semantic proximity Read ↗

Identifying druggable disease-modifying gene products.Semantic proximity Read ↗

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read ↗

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer’s DiseaseSemantic proximity Read ↗

A computational framework to find novel therapeutics for autoimmunitySemantic proximity Read ↗

Pathway and network-based strategies to translate genetic discoveries into effective therapiesSemantic proximity Read ↗

Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunitiesSemantic proximity Read ↗

GWAS and drug targets.Semantic proximity Read ↗

Advancing the use of genome-wide association studies for drug repurposing.Semantic proximity Read ↗

Targeting comorbid diseases via network endopharmacologySemantic proximity Read ↗

Integrative transcriptome-wide analysis of atopic dermatitis for drug repositioningSemantic proximity Read ↗

A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing SpondylitisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.